Ligand validation:6A19

FMN: FLAVIN MONONUCLEOTIDE

FMN is a Ligand Of Interest in 6A19 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6A19_FMN_A_401	83%	22%	0.106	0.966	1.46	1.77	6	11	0	0	100%	1
5ZZS_FMN_A_404	98%	30%	0.061	0.985	1.44	1.36	3	7	0	0	100%	1
6A0B_FMN_A_401	95%	14%	0.082	0.984	1.9	2	8	13	0	0	100%	1
6A1B_FMN_A_401	94%	17%	0.078	0.978	1.42	2.13	5	10	0	0	100%	1
6A1N_FMN_A_401	94%	29%	0.085	0.984	1.43	1.43	5	9	0	0	100%	1
5ZZR_FMN_A_401	94%	30%	0.08	0.977	1.35	1.42	4	7	0	0	100%	1
4XHF_FMN_C_300	100%	16%	0.024	0.995	2.46	1.29	11	6	0	0	100%	0.9677
1QXO_FMN_D_4004	100%	27%	0.025	0.993	1.24	1.7	2	15	1	0	100%	1
5LJI_FMN_A_201	100%	27%	0.025	0.995	1.62	1.33	5	5	0	0	100%	1
9DHH_FMN_A_401	100%	35%	0.026	0.994	1.4	1.19	5	5	0	0	100%	1
8J4W_FMN_C_201	100%	43%	0.031	0.992	1.08	1.12	2	5	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.